EPM News Update
Camargo Pharmaceutical Services, a drug development organisation specialising in the 505(b)(2) approval pathway, is adding expertise to its projects and helping postdoctoral researchers gain real-world experience through an internship programme.
In January 2014, four postdoctoral researchers joined the Camargo team at its growing Durham, North Carolina, US, location. Partnering with academic organisations, including Duke University, the internship creates hands-on opportunities across the drug development process. As research associates, the interns assist research scientists during various stages of their work, including feasibility assessments and the design and conduct of nonclinical programmes and Phase I-IV clinical trials as well as FDA regulatory preparation and filings of INDs and NDAs.
“This experience provides an opportunity for postdoctoral interns to gain experience in the regulated environment of drug development, offers a fresh perspective to our research scientists by contributing to the therapeutic breadth and ultimately helps Camargo expand our efforts,” said Gary Barnette, vice president of drug development for Camargo.
The internship can also act as a gateway to a career. In the last 20 years, there has been an increase in Ph.D. graduates countered by a decrease in academic appointments. More and more graduates with a Ph.D. are looking for positions beyond academia and that includes positions in pharmaceutical research.
“Historically, Ph.D. students and postdoctoral researchers were training for tenured faculty positions, but now only 20 percent of graduates with a Ph.D. will go on to tenured academic appointments,” said Molly Starback, director of Duke's postdoctoral services office. “Today, these postdoctoral researchers are applying for the same positions as established professionals. It has become a very competitive field, but internship programmes like Camargo’s are helping some of them get their foot in the door.”
Camargo Pharmaceutical Services, www.camargopharma.com.